Cadre Bioscience employs an efficient model to accelerate the development of multiple diverse early-stage therapeutic assets.
Cadre evaluates technologies from top-tier universities around the country and has licensed or obtained options to multiple technologies currently in development. With a portfolio of projects, a network of highly regarded advisors and consultants, and facility resources from the BioGenerator Labs, Cadre is positioned to bring life-changing solutions to patients.
By providing business, clinical development, and commercialization expertise, Cadre allows innovators to focus on advancing the science.Interested in partnering? »
Cadre's management team and advisors comprise industry veterans in pharma and drug development who know how to bring innovations to the clinic.Meet our team »
Innovations from leading research organizations are vetted by the Cadre team to identify those with the most potential to positively impact patients. Technology assets that pass Cadre's rigorous due diligence process are rapidly advanced, taking advantage of the management team's know-how, trusted consultants and CROs, and expertise of the scientific founders.Learn more about our pipeline »
Cadre was founded by BioGenerator Ventures, providing startup support and foundational capital investment. Located in the BioGenerator Labs, Cadre is positioned in the heart of St. Louis' biotech startup district close to Washington University and Saint Louis University with access to shared resources, core facilities, and world-renowned experts in biomedical science.BioGenerator Ventures »